Moreover, previous studies reported that ENO2 might be acetylated.17,18 Thus, a better understanding of the potential role of ENO2 acetylation in maintaining the malignant phenotype of PDAC cells may help identify novel potential targets for enhancing the efficacy of cancer therapeutics. Here, ENO2 is linked to cancer.